We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+3.4%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
AUM
$174M
AUM Growth
-$8.76M
Cap. Flow
-$11.5M
Cap. Flow %
-6.59%
Top 10 Hldgs %
74.19%
Holding
632
New
37
Increased
129
Reduced
104
Closed
58

Sector Composition

Rank Sector Weight
1 Healthcare 14.36%
2 Financials 5.6%
3 Technology 4.28%
4 Industrials 1.42%
5 Consumer Discretionary 1.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
1
iShares Core S&P 500 ETF
IVV
$879B
$64.5M 37.1%
109,633
-1,086
-1% -$643K
EFV icon
2
iShares MSCI EAFE Value ETF
EFV
$27.2B
$13.4M 7.7%
255,128
-1,254
-0.5% -$68.7K
IWM icon
3
iShares Russell 2000 ETF
IWM
$81.2B
$12.9M 7.4%
58,252
-741
-1% -$169K
IJR icon
4
iShares Core S&P Small-Cap ETF
IJR
$109B
$9.78M 5.62%
84,903
+7
+0% +$836
IUSV icon
5
iShares Core S&P US Value ETF
IUSV
$27B
$7.24M 4.16%
78,243
-1,106
-1% -$106K
FNA
6
DELISTED
Paragon 28, Inc.
FNA
$5.29M 3.04%
512,144
-6,001
-1% -$48.4K
WFC icon
7
Wells Fargo
WFC
$261B
$5.25M 3.02%
74,799
+29
+0% +$1.98K
DWAS icon
8
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$440M
$4.35M 2.5%
47,612
-584
-1% -$56K
IJH icon
9
iShares Core S&P Mid-Cap ETF
IJH
$121B
$3.54M 2.04%
56,889
-13,423
-19% -$861K
CNTA
10
DELISTED
Centessa Pharmaceuticals
CNTA
$2.78M 1.6%
166,135
-1,000
-0.6% -$16.6K
ATRC icon
11
AtriCure
ATRC
$1.76B
$2.56M 1.47%
83,725
+13,500
+19% +$434K
PHLT
12
DELISTED
Performant Healthcare Inc
PHLT
$2.38M 1.37%
786,550
+1,000
+0.1% +$3.44K
NVDA icon
13
NVIDIA
NVDA
$4.92T
$2.32M 1.33%
17,288
+45
+0.3% +$6.2K
AAPL icon
14
Apple
AAPL
$4.8T
$1.79M 1.03%
7,165
+135
+2% +$31.8K
NEO icon
15
NeoGenomics
NEO
$1.85B
$1.6M 0.92%
96,800
USB icon
16
US Bancorp
USB
$98.4B
$1.37M 0.79%
28,625
+206
+0.7% +$10.1K
LLY icon
17
Eli Lilly
LLY
$1.02T
$1.36M 0.78%
1,762
-476
-21% -$394K
TRV icon
18
Travelers Companies
TRV
$78.4B
$1.34M 0.77%
5,551
+28
+0.5% +$6.99K
MSFT icon
19
Microsoft
MSFT
$2.99T
$1.34M 0.77%
3,169
-127
-4% -$54.1K
MMM icon
20
3M
MMM
$83B
$1.12M 0.64%
8,687
-1,094
-11% -$143K
CRNX icon
21
Crinetics Pharmaceuticals
CRNX
$8.88B
$1.02M 0.59%
19,995
PLRX icon
22
Pliant Therapeutics
PLRX
$66.3M
$988K 0.57%
75,000
+7,500
+11% +$102K
ATEC icon
23
Alphatec Holdings
ATEC
$1.27B
$912K 0.52%
99,400
-8,000
-7% -$63.9K
TNDM icon
24
Tandem Diabetes Care
TNDM
$1.24B
$907K 0.52%
25,170
-2,000
-7% -$67.7K
SPY icon
25
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$842K 0.48%
1,437
+288
+25% +$170K

Similar funds

HighMark Wealth Management's Q4 2024 Portfolio in Review

As of Q4 2024, HighMark Wealth Management held 632 positions worth $174M, down 4.8% from $183M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

HighMark Wealth Management withdrew a net $11.5M in Q4 2024, closing 58 positions and reducing 104 holdings. Its most notable exit was iShares 20+ Year Treasury Bond ETF, an estimated $1.54M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

Against the trend, HighMark Wealth Management opened a new position in Bridger Aerospace worth $128K.

  • HighMark Wealth Management's largest Q4 2024 buy was Bridger Aerospace: 60,162 shares worth $128K.
  • HighMark Wealth Management added most to AtriCure in Q4 2024, an estimated $434K increase.
  • HighMark Wealth Management's biggest Q4 2024 reduction was iShares S&P 500 Value ETF, cutting an estimated $1.5M.
  • HighMark Wealth Management fully exited iShares 20+ Year Treasury Bond ETF in Q4 2024, selling an estimated $1.54M.
  • HighMark Wealth Management's ten largest holdings make up 74% of its $174M portfolio in Q4 2024.
  • HighMark Wealth Management opened 37 new positions and closed 58 in Q4 2024.
  • HighMark Wealth Management's portfolio value fell 4.8% quarter-over-quarter to $174M.

Based on HighMark Wealth Management's 13F filing for Q4 2024, filed 31 Jan 2025.